News
The FDA has expanded the approval of Dextenza (dexamethasone ophthalmic insert) to include pediatric treatment.
17h
Clinical Trials Arena on MSNOculis completes enrolment in trials for diabetic macular oedema eye dropsOculis Holding has concluded subject enrolment for the Phase III DIAMOND-1 and DIAMOND-2 clinical trials of OCS-01 eye drops ...
The U.S. Food and Drug Administration has approved a prefilled syringe version of Netherlands-based Argenx SE's blockbuster ...
A new drug application has been submitted for Brimocholâ„¢ PF (Tenpoint Therapeutics Ltd.) for the treatment of presbyopia.
A new eyedrop innovation for dogs offers better treatment for bacterial eye infections and could aid human medicine.
The bloodbath in Wall Street looks set to extend into the new week, says Yeap Jun Rong, market strategist at trading ...
Project Community Connect returns to Missoula Public Library, offering free services to our neighbors in need on April 11, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results